Visteon Corporation
NASDAQ:VCAuto - Parts
+$0.73 today
- Market cap
- $1.98B
- Beta
- 1.27
- P/E (TTM)
- 18.0
- EPS (TTM)
- $6.16
- Dividend yield
- 1.17%
Volume 0.49M
Average 0.56M
VC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Visteon CorporationNASDAQ: VC
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $88M a year earlier. Trailing-twelve-month research & development was $0. Over 3 fiscal years it compounded at +3.9% a year.
Context
- Research & development amounted to 5.8% of revenue in FY2025, up 0.9 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 220M USD
- Year-over-year change
- +15.2%
- 4-year CAGR
- +3.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 220M | +15.2% |
| FY2024 | 2024-12-31 | 191M | -9.0% |
| FY2023 | 2023-12-31 | 210M | +7.1% |
| FY2022 | 2022-12-31 | 196M | +2.6% |
| FY2021 | 2021-12-31 | 191M | — |
Research & Development vs competitors
How VC compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the lowest of 8, against a peer median of +0.6%.
- Research & development amounts to 0.0% of revenue for VC, versus a peer median of 54.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.12B USD | -1.5% | +13.4% | 55.8% | |
| LTM Jun 2026 | CN¥850.26M CNY | +0.6% | +12.8% | 25.5% | |
| LTM Jul 2026 | $228.69M USD | -2.2% | +5.2% | 54.7% | |
| LTM Sep 2026 | $205.71M USD | +4.4% | +15.1% | 7.9% | |
| LTM Mar 2026 | $77M USD | +8.1% | +2.1% | 68.5% | |
| LTM Mar 2026 | $54.03M USD | -25.1% | -2.7% | 6.7% | |
| LTM Mar 2026 | $42.36M USD | +3.5% | -9.8% | 60.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | +3.9% | 0.0% | |
| Peer median (excluding VC) | — | +0.6% | +5.2% | 54.7% | |
Competitors are the stored peer set for VC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.77B | 3.76B | 3.95B | 3.87B | 3.77B |
| Cost of Revenue | 2.32B | 3.18B | 3.26B | 3.34B | 3.24B |
| Gross Profit | 453M | 572M | 697M | 531M | 532M |
| Gross Margin | 16.3% | 15.2% | 17.6% | 13.7% | 14.1% |
| Research & Development | 191M | 196M | 210M | 191M | 220M |
| Selling, General & Admin | 175M | 188M | 207M | 207M | 202M |
| Operating Expenses | 366M | 384M | 417M | 398M | 202M |
| Depreciation & Amortization | 108M | 108M | 104M | 96M | 109M |
| EBITDA | 199M | 295M | 366M | 409M | 451M |
| EBITDA Margin | 7.2% | 7.9% | 9.3% | 10.6% | 12.0% |
| Operating Income | 87M | 188M | 280M | 133M | 330M |
| Operating Margin | 3.1% | 5.0% | 7.1% | 3.4% | 8.8% |
| Interest Income | 2M | 4M | 10M | 17M | 22M |
| Interest Expense | 10M | 14M | 17M | 15M | 4M |
| Other Income / Expenses | (6M) | (13M) | (23M) | 165M | 8M |
| Income Before Tax | 81M | 175M | 257M | 298M | 338M |
| Pre-Tax Margin | 2.9% | 4.7% | 6.5% | 7.7% | 9.0% |
| Income Tax Expense | 31M | 45M | (248M) | 14M | 125M |
| Net Income | 41M | 124M | 486M | 274M | 201M |
| Net Margin | 1.5% | 3.3% | 12.3% | 7.1% | 5.3% |
| EPS (Basic) | 1.46 | 4.41 | 17.30 | 9.95 | 7.39 |
| EPS (Diluted) | 1.44 | 4.35 | 17.05 | 9.82 | 7.28 |
| Weighted Avg Shares | 28M | 28.1M | 28.1M | 27.55M | 27.2M |
| Weighted Avg Shares (Diluted) | 28.4M | 28.5M | 28.5M | 27.9M | 27.6M |
Visteon Corporation
NASDAQ:VC
Intrinsic Alpha fair value
Locked
Current Price
$80.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.